The stock of Alkermes plc (ALKS) has gone up by 1.15% for the week, with a -9.91% drop in the past month and a -10.47% drop in the past quarter. The volatility ratio for the week is 2.57%, and the volatility levels for the past 30 days are 2.97% for ALKS. The simple moving average for the last 20 days is -1.77% for ALKS’s stock, with a simple moving average of -7.90% for the last 200 days.
Is It Worth Investing in Alkermes plc (NASDAQ: ALKS) Right Now?
The price-to-earnings ratio for Alkermes plc (NASDAQ: ALKS) is above average at 11.86x. The 36-month beta value for ALKS is also noteworthy at 0.60. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALKS is 166.70M, and at present, short sellers hold a 8.11% of that float. The average trading volume of ALKS on May 01, 2024 was 2.01M shares.
ALKS) stock’s latest price update
The stock of Alkermes plc (NASDAQ: ALKS) has decreased by -1.37 when compared to last closing price of 24.88.Despite this, the company has seen a gain of 1.15% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-22 that Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
Analysts’ Opinion of ALKS
Many brokerage firms have already submitted their reports for ALKS stocks, with Robert W. Baird repeating the rating for ALKS by listing it as a “Outperform.” The predicted price for ALKS in the upcoming period, according to Robert W. Baird is $37 based on the research report published on March 19, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see ALKS reach a price target of $25. The rating they have provided for ALKS stocks is “Sell” according to the report published on February 20th, 2024.
JP Morgan gave a rating of “Neutral” to ALKS, setting the target price at $33 in the report published on November 20th of the previous year.
ALKS Trading at -9.98% from the 50-Day Moving Average
After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.36% of loss for the given period.
Volatility was left at 2.97%, however, over the last 30 days, the volatility rate increased by 2.57%, as shares sank -8.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.74% lower at present.
During the last 5 trading sessions, ALKS rose by +1.15%, which changed the moving average for the period of 200-days by -19.38% in comparison to the 20-day moving average, which settled at $24.87. In addition, Alkermes plc saw -11.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALKS starting from Nichols Christian Todd, who sale 10,417 shares at the price of $28.10 back on Mar 18 ’24. After this action, Nichols Christian Todd now owns 65,911 shares of Alkermes plc, valued at $292,740 using the latest closing price.
Parisi Samuel Joseph, the VP, Finance (Interim PAO) of Alkermes plc, sale 2,559 shares at $29.65 during a trade that took place back on Feb 27 ’24, which means that Parisi Samuel Joseph is holding 7,717 shares at $75,874 based on the most recent closing price.
Stock Fundamentals for ALKS
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.78 for the gross margin
The net margin for Alkermes plc stands at 0.21. The total capital return value is set at 0.18. Equity return is now at value 35.93, with 19.68 for asset returns.
Based on Alkermes plc (ALKS), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 1.38. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is 12.6.
Currently, EBITDA for the company is 486.73 million with net debt to EBITDA at -0.47. When we switch over and look at the enterprise to sales, we see a ratio of 2.36. The receivables turnover for the company is 4.99for trailing twelve months and the total asset turnover is 0.78. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.86.
Conclusion
In summary, Alkermes plc (ALKS) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
